|
|
Recombinant adeno-associated virus-based gene therapy combined with tissue engineering for musculoskeletal regenerative medicine
|
Yiqing Wang, Xiangyu Chu, Bing Wang
|
|
|
Table 3 Biomaterial-mediated AAV gene delivery for musculoskeletal tissue repair
|
|
Gene | AAV serotype | Scaffold | Biomaterial source | Clinical application | Reference | BMP-2 | AAV6 | Hydrogel | Gelatine | Cranial bone formation | 70 | | AAV6 | Porous | PLLA | Bone formation | 78 | | AAV2.5 | Porous | PCL | Femoral bone formation | 92 | SOX9 | AAV2 | Micelles | PEO-PPO-PEO copolymer | Cartilage repair | 102 | | AAV2 | Films | PCL | Cartilage repair | 103 | TGF-β | AAV2 | Micelles | PEO-PPO copolymer | Cartilage repair | 101 | VEGF | AAV2 & AAV9 | Fibrous | PEUU & PEEUU | Cardiac tissue regeneration | 40 | | AAV2 | Matrix | Collagen & glycosaminoglycan | Muscle regeneration | 106 |
|
|
|